132 related articles for article (PubMed ID: 27758881)
41. Vascular endothelial growth factor independently predicts the efficacy of postoperative radiotherapy in node-negative breast cancer patients.
Manders P; Sweep FC; Tjan-Heijnen VC; Geurts-Moespot A; van Tienoven DT; Foekens JA; Span PN; Bussink J; Beex LV
Clin Cancer Res; 2003 Dec; 9(17):6363-70. PubMed ID: 14695136
[TBL] [Abstract][Full Text] [Related]
42. Redox-Responsive Manganese Dioxide Nanoparticles for Enhanced MR Imaging and Radiotherapy of Lung Cancer.
Cho MH; Choi ES; Kim S; Goh SH; Choi Y
Front Chem; 2017; 5():109. PubMed ID: 29255705
[TBL] [Abstract][Full Text] [Related]
43. Oxidative Stress-Induced DNA Damage by Manganese Dioxide Nanoparticles in Human Neuronal Cells.
Alarifi S; Ali D; Alkahtani S
Biomed Res Int; 2017; 2017():5478790. PubMed ID: 28596964
[TBL] [Abstract][Full Text] [Related]
44. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.
Leung E; Cairns RA; Chaudary N; Vellanki RN; Kalliomaki T; Moriyama EH; Mujcic H; Wilson BC; Wouters BG; Hill R; Milosevic M
BMC Cancer; 2017 Jun; 17(1):418. PubMed ID: 28619042
[TBL] [Abstract][Full Text] [Related]
45. MnO2-modified persistent luminescence nanoparticles for detection and imaging of glutathione in living cells and in vivo.
Li N; Diao W; Han Y; Pan W; Zhang T; Tang B
Chemistry; 2014 Dec; 20(50):16488-91. PubMed ID: 25352246
[TBL] [Abstract][Full Text] [Related]
46. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K
Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594
[TBL] [Abstract][Full Text] [Related]
47. In situ formation of large pore silica-MnO
He Z; Xiao Y; Zhang JR; Zhang P; Zhu JJ
Chem Commun (Camb); 2018 Mar; 54(24):2962-2965. PubMed ID: 29388991
[TBL] [Abstract][Full Text] [Related]
48. [Formation and reactions of biogenic manganese oxides with heavy metals in environment].
Meng YT; Zheng YM; Zhang LM; He JZ
Huan Jing Ke Xue; 2009 Feb; 30(2):574-82. PubMed ID: 19402518
[TBL] [Abstract][Full Text] [Related]
49. Preclinical Efficacy of Bevacizumab with CRLX101, an Investigational Nanoparticle-Drug Conjugate, in Treatment of Metastatic Triple-Negative Breast Cancer.
Pham E; Yin M; Peters CG; Lee CR; Brown D; Xu P; Man S; Jayaraman L; Rohde E; Chow A; Lazarus D; Eliasof S; Foster FS; Kerbel RS
Cancer Res; 2016 Aug; 76(15):4493-503. PubMed ID: 27325647
[TBL] [Abstract][Full Text] [Related]
50. Combination of Gold Nanoparticle-Conjugated Tumor Necrosis Factor-α and Radiation Therapy Results in a Synergistic Antitumor Response in Murine Carcinoma Models.
Koonce NA; Quick CM; Hardee ME; Jamshidi-Parsian A; Dent JA; Paciotti GF; Nedosekin D; Dings RP; Griffin RJ
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):588-96. PubMed ID: 26461001
[TBL] [Abstract][Full Text] [Related]
51. A pilot study of the effects of mild systemic heating on human head and neck tumour xenografts: Analysis of tumour perfusion, interstitial fluid pressure, hypoxia and efficacy of radiation therapy.
Winslow TB; Eranki A; Ullas S; Singh AK; Repasky EA; Sen A
Int J Hyperthermia; 2015; 31(6):693-701. PubMed ID: 25986432
[TBL] [Abstract][Full Text] [Related]
52. Tumor Hypoxia Regulates Forkhead Box C1 to Promote Lung Cancer Progression.
Lin YJ; Shyu WC; Chang CW; Wang CC; Wu CP; Lee HT; Chen LJ; Hsieh CH
Theranostics; 2017; 7(5):1177-1191. PubMed ID: 28435457
[TBL] [Abstract][Full Text] [Related]
53. Selective Reversible Inhibition of Autophagy in Hypoxic Breast Cancer Cells Promotes Pulmonary Metastasis.
Dower CM; Bhat N; Wang EW; Wang HG
Cancer Res; 2017 Feb; 77(3):646-657. PubMed ID: 28115361
[TBL] [Abstract][Full Text] [Related]
54. Novel nanosystem to enhance the antitumor activity of lapatinib in breast cancer treatment: Therapeutic efficacy evaluation.
Huo ZJ; Wang SJ; Wang ZQ; Zuo WS; Liu P; Pang B; Liu K
Cancer Sci; 2015 Oct; 106(10):1429-37. PubMed ID: 26177628
[TBL] [Abstract][Full Text] [Related]
55. MnO
Zhang YH; Qiu WX; Zhang M; Zhang L; Zhang XZ
ACS Appl Mater Interfaces; 2018 May; 10(17):15030-15039. PubMed ID: 29633614
[TBL] [Abstract][Full Text] [Related]
56. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
[TBL] [Abstract][Full Text] [Related]
57. Oxygen-generating hybrid nanoparticles to enhance fluorescent/photoacoustic/ultrasound imaging guided tumor photodynamic therapy.
Gao S; Wang G; Qin Z; Wang X; Zhao G; Ma Q; Zhu L
Biomaterials; 2017 Jan; 112():324-335. PubMed ID: 27776285
[TBL] [Abstract][Full Text] [Related]
58. Role of enolase-1 in response to hypoxia in breast cancer: exploring the mechanisms of action.
Gao J; Zhao R; Xue Y; Niu Z; Cui K; Yu F; Zhang B; Li S
Oncol Rep; 2013 Apr; 29(4):1322-32. PubMed ID: 23381546
[TBL] [Abstract][Full Text] [Related]
59. The timing of surgery after neoadjuvant radiotherapy influences tumor dissemination in a preclinical model.
Leroi N; Sounni NE; Van Overmeire E; Blacher S; Marée R; Van Ginderachter J; Lallemand F; Lenaerts E; Coucke P; Noel A; Martinive P
Oncotarget; 2015 Nov; 6(34):36825-37. PubMed ID: 26440148
[TBL] [Abstract][Full Text] [Related]
60. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
